Categories: Wire Stories

Echodyne Invited to FAA Unmanned Aircraft System Beyond Visual Line-of-Sight (BVLOS) Aviation Rulemaking Committee

Members of the ARC to provide recommendations shaping UAS regulation

SEATTLE–(BUSINESS WIRE)–Echodyne, the radar platform company, announced today that it has been invited by the Federal Aviation Administration (FAA) to join the Unmanned Aircraft System (UAS) Beyond Visual Line-of-Sight (BVLOS) Aviation Rulemaking Committee (ARC). Echodyne, among other industry leaders, will play a key role in defining the future of unmanned aircraft integration into the United States� National Airspace System and regulation to ensure safety, security, and compliance.

“The formation of this committee represents a strong step forward for the broader UAS industry as we move towards a future of autonomous machines,” said Eben Frankenberg, CEO of Echodyne. “We have developed significant experience in the area of airspace situational awareness through our work with a range of commercial customers, government agencies, and UAS test centers. We look forward to contributing our expertise and learnings to this important Aviation Rulemaking Committee.”

The UAS BVLOS ARC will be responsible for providing recommendations to the FAA for regulatory requirements to normalize safe, scalable, economically viable, and environmentally advantageous unmanned operations. The committee will use a performance-based, technology agnostic regulatory framework to address a wide variety of use cases, including:

  • Long-line linear infrastructure inspections
  • Industrial aerial data gathering
  • Small package delivery
  • And precision agriculture operations.

The FAA’s UAS BVLOS ARC was established to advance safe and secure integration of unmanned systems. The FAA has the sole authority to coordinate and task Aviation Rulemaking Committees (ARCs), which provide information, advice, and recommendations to the FAA. For more information on the UAS BVLOS ARC, visit https://www.faa.gov/.

About Echodyne

Echodyne, the radar platform company, designs and delivers high-performance compact, solid-state, patent-protected MESA® radars. Ideally suited for defense, security, machine perception, and autonomy, Echodyne’s commercially priced electronically-scanned array radars are used by defense and government agencies, autonomous developers, and security integrators for counter-UAS, borders and perimeter security, critical infrastructure protection, unmanned aerial vehicles, and autonomous vehicles. Privately held, the company is based in Kirkland, Washington, and is backed by Bill Gates, NEA, Madrona Venture Group, Vulcan Capital, Vanedge Capital, and Lux Capital among others. For more information, please visit: Echodyne.com.

Contacts

Sarah Pugsley

echodyne@strangebrewstrategies.com

Alex

Recent Posts

Fabrinet Announces Third Quarter Fiscal Year 2024 Financial Results

Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…

4 hours ago

South Korea Data Center Market Investment Analysis Report 2024-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…

7 hours ago

Revitalized “Marco Polo” Opera Celebrates Sino-Italian Ties at Guangzhou Opera House

GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…

8 hours ago

BrainChip Earns Australian Patent for Improved Spiking Neural Network

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…

8 hours ago

NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson…

9 hours ago

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on…

10 hours ago